Biologics in COPD: Why, when, and who

from The APAPP Podcast · host Association of Pulmonary Advanced Practice Providers

Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients. Claim your 0.5 CME credits here: https://forms.gle/42yHmF8UpemVhdDJA

Episode metadata supplied by the publisher feed · Published May 31, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Biologics in COPD: Why, when, and who

0:00 23:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The APAPP Podcast?

This episode is 23 minutes long.

When was this The APAPP Podcast episode published?

This episode was published on May 31, 2024.

Can I download this The APAPP Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!